Filing Details
- Accession Number:
- 0001127602-24-009007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-07 16:10:27
- Reporting Period:
- 2024-03-06
- Accepted Time:
- 2024-03-07 16:10:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1462354 | A Kurt Gustafson | C/O Xencor, Inc. 465 N Halstead Street, Suite 200 Pasadena CA 91107 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-03-06 | 15,000 | $10.73 | 20,007 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-03-06 | 14,000 | $23.18 | 6,007 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-03-06 | 15,000 | $0.00 | 15,000 | $10.73 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2024-07-13 | No | 4 | M | Direct |
Footnotes
- Underlying option due to expire in July 2024.
- Represents the disposition of shares sold to pay option cost and estimated tax liability due upon option exercise.
- 1/3 of the shares subject to the stock option vest and become exercisable on July 14, 2015, and the remaining shares vest in equal monthly installments over the subsequent 24 months.